What is the address of DR. B. CLAES?

The registered office of DR. B. CLAES is located at Lijsterbessenweg 11, 2540 Hove.

Is DR. B. CLAES still active?

Yes. According to the CBE (30 October 2026) DR. B. CLAES is active, legal situation “Normale toestand”, started on 12 June 2002.

Is DR. B. CLAES registered on Peppol?

No, DR. B. CLAES is currently not registered on the Peppol network.

What is the enterprise number of DR. B. CLAES?

The enterprise number of DR. B. CLAES is BE0477731037.

When was DR. B. CLAES founded?

DR. B. CLAES was founded on 12 June 2002.

Who are the directors of DR. B. CLAES?

According to the 2025 annual accounts, the directors of DR. B. CLAES are: Brigitte CLAES.

Is DR. B. CLAES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 June 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. B. CLAES make in 2025?

DR. B. CLAES posted a profit after taxes of € 250,753 in financial year 2025.

What is the revenue of DR. B. CLAES?

As a small company, DR. B. CLAES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 417,871.

DR. B. CLAES (Private Limited) - Hove - BE0477731037

Dossier DR. B. CLAES, printed on 30 October 2026 from databakkes.be/en/0477731037/dr-b-claes. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2022.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. B. CLAES from Hove, company number BE0477731037, closed financial year 2025 with a result of € 250,753 after tax. For that financial year DR. B. CLAES recorded a gross margin of € 417,871 and equity of € 2.2 million. Compared with financial year 2024, the result moved from € 254,529 to € 250,753. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 2.2 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 250,753

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 475,203

▲ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

0 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 8,252

▼ 73% vs 2024

Of which on lease € 6,357.

Debts at end 2025

Bank debt

€ 5,364

▼ 80% vs 2024

Loans from banks and other lenders, long and short.

Taxes

€ 31,878

▲ 69% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 437,831 Gross margin 2022: € 437,831 First fiscal year in the series	€ 400,559 Gross margin 2023: € 400,559 ▼ 9% vs 2022 (€ 437,831) Unfavourable step	€ 423,453 Gross margin 2024: € 423,453 ▲ 6% vs 2023 (€ 400,559) Favourable step	€ 417,871 Gross margin 2025: € 417,871 ▼ 1% vs 2024 (€ 423,453) Unfavourable step	▼ 1%
Profit after taxes	€ 264,995 Profit after taxes 2022: € 264,995 First fiscal year in the series	€ 233,445 Profit after taxes 2023: € 233,445 ▼ 12% vs 2022 (€ 264,995) Unfavourable step	€ 254,529 Profit after taxes 2024: € 254,529 ▲ 9% vs 2023 (€ 233,445) Favourable step	€ 250,753 Profit after taxes 2025: € 250,753 ▼ 1% vs 2024 (€ 254,529) Unfavourable step	▼ 1%
Equity	€ 1,458,981 Equity 2022: € 1,458,981 First fiscal year in the series	€ 1,691,593 Equity 2023: € 1,691,593 ▲ 16% vs 2022 (€ 1,458,981) Favourable step	€ 1,945,264 Equity 2024: € 1,945,264 ▲ 15% vs 2023 (€ 1,691,593) Favourable step	€ 2,195,184 Equity 2025: € 2,195,184 ▲ 13% vs 2024 (€ 1,945,264) Favourable step	▲ 13%
Total debts	€ 1,004,684 Total debts 2022: € 1,004,684 First fiscal year in the series	€ 846,310 Total debts 2023: € 846,310 ▼ 16% vs 2022 (€ 1,004,684) Favourable step	€ 713,015 Total debts 2024: € 713,015 ▼ 16% vs 2023 (€ 846,310) Favourable step	€ 575,091 Total debts 2025: € 575,091 ▼ 19% vs 2024 (€ 713,015) Favourable step	▼ 19%
Cash	€ 295,014 Cash 2022: € 295,014 First fiscal year in the series	€ 278,691 Cash 2023: € 278,691 ▼ 6% vs 2022 (€ 295,014) Unfavourable step	€ 409,181 Cash 2024: € 409,181 ▲ 47% vs 2023 (€ 278,691) Favourable step	€ 475,203 Cash 2025: € 475,203 ▲ 16% vs 2024 (€ 409,181) Favourable step	▲ 16%
Retained profit	€ 1,452,781 Retained profit 2022: € 1,452,781 First fiscal year in the series	€ 1,685,393 Retained profit 2023: € 1,685,393 ▲ 16% vs 2022 (€ 1,452,781) Favourable step	€ 1,939,064 Retained profit 2024: € 1,939,064 ▲ 15% vs 2023 (€ 1,685,393) Favourable step	€ 2,188,984 Retained profit 2025: € 2,188,984 ▲ 13% vs 2024 (€ 1,939,064) Favourable step	▲ 13%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 859 Dividend 2024: € 859 ▲ 3% vs 2023 (€ 833) Unchanged	€ 833 Dividend 2025: € 833 ▼ 3% vs 2024 (€ 859) Unchanged	▼ 3%
Bank debt	€ 68,785 Bank debt 2022: € 68,785 First fiscal year in the series	€ 47,838 Bank debt 2023: € 47,838 ▼ 30% vs 2022 (€ 68,785) Favourable step	€ 26,698 Bank debt 2024: € 26,698 ▼ 44% vs 2023 (€ 47,838) Favourable step	€ 5,364 Bank debt 2025: € 5,364 ▼ 80% vs 2024 (€ 26,698) Favourable step	▼ 80%
Balance sheet total	€ 2,463,665 Balance sheet total 2022: € 2,463,665 First fiscal year in the series	€ 2,537,903 Balance sheet total 2023: € 2,537,903 ▲ 3% vs 2022 (€ 2,463,665) Unchanged	€ 2,658,279 Balance sheet total 2024: € 2,658,279 ▲ 5% vs 2023 (€ 2,537,903) Unchanged	€ 2,770,274 Balance sheet total 2025: € 2,770,274 ▲ 4% vs 2024 (€ 2,658,279) Unchanged	▲ 4%

Key figures of DR. B. CLAES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. B. CLAES?

What happened at DR. B. CLAES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Brigitte CLAES stepped down as director. NBB
Jul 8, 2026 New annual accounts for financial year 2025: profit of € 250,753 (▼ 1% vs 2024). Source: NBB ↗
2020 Brigitte CLAES became a director. NBB
Jun 1, 2005 New establishment in Antwerpen. KBO
Jun 12, 2002 Start of the company according to the CBE. KBO

In short

From € 264,995 profit in 2022 to € 250,753 profit in 2025.

Paid € 477,559 in corporate taxes since 2022.

Best year ever: 2022, with € 264,995 profit.

Paid out € 3,325 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Brigitte CLAES

Director

since 2020 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Lijsterbessenweg 11

2540 Hove

2.302.013.007

Florent Pauwelslei 1

2100 Antwerpen

Active since 1 June 2005

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0477.731.037
VAT number: BE 0477.731.037
Registered office: Lijsterbessenweg 11, 2540 Hove
Names & denominations: DR. B. CLAES
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 June 2002
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. B. CLAES